Dexcom (DXCM) EPS (Basic) (QoQ) (2010 - 2026)
Dexcom (DXCM) EPS (Basic) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.52 Bn | 175.22 Bn | 6.27 Bn |
| 2 | Stryker | 128.96 Bn | 126.09 Bn | 3.81 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.76 Bn | 66.31 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.09 Bn | 44.41 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.61 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.02 Bn | 26.45 Bn | - |
| 9 | Koninklijke Philips | 23.98 Bn | 20.86 Bn | 2.07 Bn |
| 10 | Steris | 21.45 Bn | 21.01 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.38% |
| Dec 31, 2025 | -5.60% |
| Sep 30, 2025 | 58.25% |
| Jun 30, 2025 | 70.15% |
| Mar 31, 2025 | -30.08% |
| Dec 31, 2024 | 12.88% |
| Sep 30, 2024 | -5.01% |
| Jun 30, 2024 | -4.19% |
| Mar 31, 2024 | -43.49% |
| Dec 31, 2023 | 112.67% |
| Sep 30, 2023 | 4.17% |
| Jun 30, 2023 | 138.48% |
| Mar 31, 2023 | -46.69% |
| Dec 31, 2022 | -9.20% |
| Sep 30, 2022 | 100.20% |
| Jun 30, 2022 | -48.18% |
| Mar 31, 2022 | 1,926.41% |
| Dec 31, 2021 | -106.08% |
| Sep 30, 2021 | 11.12% |
| Jun 30, 2021 | 38.19% |